Editorials
The Tamiflu trials
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2630 (Published 09 April 2014) Cite this as: BMJ 2014;348:g2630
Related articles
- Research Published: 09 April 2014; BMJ 348 doi:10.1136/bmj.g2545
- Research Published: 09 April 2014; BMJ 348 doi:10.1136/bmj.g2547
- Editorial Published: 09 April 2014; BMJ 348 doi:10.1136/bmj.g2548
- Feature Published: 08 December 2009; BMJ 339 doi:10.1136/bmj.b5387
- Observations Published: 12 December 2012; BMJ 345 doi:10.1136/bmj.e8415
- Feature Published: 04 June 2010; BMJ 340 doi:10.1136/bmj.c2912
- Analysis Published: 08 December 2009; BMJ 339 doi:10.1136/bmj.b5164
- Editorial Published: 08 December 2009; BMJ 339 doi:10.1136/bmj.b5351
- Observations Published: 29 October 2012; BMJ 345 doi:10.1136/bmj.e7305
- Editor's Choice Published: 10 April 2014; BMJ 348 doi:10.1136/bmj.g2695
- Analysis Published: 10 April 2014; BMJ 348 doi:10.1136/bmj.g2263
- Letter Published: 08 December 2009; BMJ 339 doi:10.1136/bmj.b5374
- Student Published: 11 June 2014; BMJ 348 doi:10.1136/sbmj.g3288
- Editorial Published: 08 January 2020; BMJ 368 doi:10.1136/bmj.m10
See more
- US women must be told breast density after mammogram, says FDABMJ September 18, 2024, 386 q2045; DOI: https://doi.org/10.1136/bmj.q2045
- Semaglutide’s CVD indication could cost US Medicare $145bn extra a yearBMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878
- Microdosing mushroom sweet treats are recalled in US after six hospital admissions and two potential deathsBMJ August 27, 2024, 386 q1871; DOI: https://doi.org/10.1136/bmj.q1871
- Over-the-counter painkillers may not be sufficient when fitting IUDs, says US agencyBMJ August 19, 2024, 386 q1820; DOI: https://doi.org/10.1136/bmj.q1820
- Michael Bloomberg donates $600m to historically black US medical schoolsBMJ August 08, 2024, 386 q1766; DOI: https://doi.org/10.1136/bmj.q1766
Cited by...
- How to use the regulatory data from Health Canada for secondary analyses on new drugs, biologics and vaccines
- Defending transparency at European drug regulator
- Was the flu drug zanamivir a breakthrough or money for old rope?
- Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis